Trials / Completed
CompletedNCT03161080
Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The prevalence and incidence of dry eye syndrome (DES) is constantly increasing. Several therapeutic strategies have been proposed, but still no ideal regimen has been found. Recently, a new method for the non- invasive measurement of tear film thickness (TFT) based on optical coherence tomography (OCT) has been developed. It has been shown in previous studies that TFT correlates well with objective signs as well as with subjective symptoms of DES. In the present study the effects of three different topical lubricants (Neovis total multi®, Vismed multi® and Hydrabak® eye drops) on tear film thickness in patients with moderate to severe DES will be investigated using this device. Tear film thickness will be measured at baseline and at defined time points after single instillation. The course of tear film thickness during this study day will provide information about the corneal residency time of the three different eye drops. Patients with moderate to severe DES will be randomized to receive either Neovis total multi®, Vismed multi® or Hydrabak® eye drops. Assessment of lipid layer thickness of the tear film will be performed before and at pre-specified time points after instillation as secondary outcome. Other clinical measures for DES such as determination of tear film break up time (TFBUT), corneal fluorescein staining, Schirmer I test and subjective assessments will also be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neovis Total Multi® Eye Drops | Eye Drops containing Sodium hyaluronate (0.18%), lipoic acid, hydroxypropyl methylcellulose |
| DEVICE | Vismed Multi® Eye Drops | Eye Drops containing Sodium hyaluronate (0.18%), potassium chloride, disodium phosphate |
| DEVICE | Hydrabak® Eye Drops | Eye Drops containing sodium chloride (0,9%), sodium dihydrogen phosphate dehydrate |
Timeline
- Start date
- 2017-02-09
- Primary completion
- 2017-05-12
- Completion
- 2017-05-12
- First posted
- 2017-05-19
- Last updated
- 2019-08-22
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03161080. Inclusion in this directory is not an endorsement.